Last reviewed · How we verify
NCT03632057: EFICAZ
Shock Efficacy Study Comparing Fixed Tilt and Fixed Pulse Width in a General Implantable-Cardioverter Population
NA trial testing Fixed Tilt (65%) in Ventricular Arrythmia in 779 participants. Completed in 18 April 2025.
18 April 2025
Quick facts
| Lead sponsor | Abbott Medical Devices |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 779 |
| Start date | 6 June 2018 |
| Primary completion | 18 April 2025 |
| Estimated completion | 18 April 2025 |
| Sites | 2 locations across Spain |
Drugs / interventions tested
- Fixed Tilt (65%)
- Fixed Pulse Width
Conditions studied
- Ventricular Arrythmia — all drugs for Ventricular Arrythmia →
Sponsor
Abbott Medical Devices — full company profile →
Who can join
18 and older, any sex, with Ventricular Arrythmia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, 1:1 randomized, interventional, multicenter and international trial. Approximately 790 subjects are expected to be enrolled to 40 sites in the south of Europe and Middle East.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03632057
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ventricular Arrythmia
Currently open trials in the same condition.
- NCT06360939 — Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease · NA · recruiting
- NCT06889662 — GEAM Study Aims At Assessing the Role of Genetic Testing in Patients with Arrhythmic Myocarditis. · recruiting
- NCT06592001 — Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study · NA · active not recruiting
- NCT07196397 — POLish Registry of CArdioneuroablation and CArdioneuromodulation · recruiting
- NCT06071910 — Emergency Resuscitative Endovascular Balloon Occlusion of the Aorta in Out of Hospital Cardiac Arrest · NA · recruiting
Other Abbott Medical Devices trials
Trials by the same sponsor.
- NCT07421076 — Grid eXplore Mapping Study · NA · recruiting
- NCT07509658 — TriClip Japan Post-Approval Study · recruiting
- NCT07361445 — Agilis RF TSP Early Feasibility Study · NA · recruiting
- NCT07373353 — A Clinical Evaluation of AMJ-401 · NA · recruiting
- NCT07217392 — Left Bundle Branch Area Pacing (LBBAP) PMCF Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03632057 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Abbott Medical Devices
- Last refreshed: 7 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03632057.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing